An updated reappraisal of dupilumab in children and adolescents with moderate-severe atopic dermatitis.

MLA

Ciprandi, Giorgio, et al. “An Updated Reappraisal of Dupilumab in Children and Adolescents with Moderate-Severe Atopic Dermatitis.” Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, vol. 35, no. 6, June 2024, p. e14181. EBSCOhost, https://doi.org/10.1111/pai.14181.

APA

Ciprandi, G., Licari, A., Tosca, M. A., Miraglia Del Giudice, M., Belloni Fortina, A., & Marseglia, G. L. (2024). An updated reappraisal of dupilumab in children and adolescents with moderate-severe atopic dermatitis. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, 35(6), e14181. https://doi.org/10.1111/pai.14181

Chicago

Ciprandi, Giorgio, Amelia Licari, Maria Angela Tosca, Michele Miraglia Del Giudice, Anna Belloni Fortina, and Gian Luigi Marseglia. 2024. “An Updated Reappraisal of Dupilumab in Children and Adolescents with Moderate-Severe Atopic Dermatitis.” Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology 35 (6): e14181. doi:10.1111/pai.14181.